WO2000026244A3 - A novel tumor necrosis factor family member, drl, and related compositions and methods - Google Patents
A novel tumor necrosis factor family member, drl, and related compositions and methods Download PDFInfo
- Publication number
- WO2000026244A3 WO2000026244A3 PCT/US1999/025954 US9925954W WO0026244A3 WO 2000026244 A3 WO2000026244 A3 WO 2000026244A3 US 9925954 W US9925954 W US 9925954W WO 0026244 A3 WO0026244 A3 WO 0026244A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drl
- seq
- set forth
- provides
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU14670/00A AU1467000A (en) | 1998-11-04 | 1999-11-04 | A novel tumor necrosis factor family member, drl, and related compositions and methods |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10697698P | 1998-11-04 | 1998-11-04 | |
US60/106,976 | 1998-11-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000026244A2 WO2000026244A2 (en) | 2000-05-11 |
WO2000026244A3 true WO2000026244A3 (en) | 2000-11-09 |
Family
ID=22314220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/025954 WO2000026244A2 (en) | 1998-11-04 | 1999-11-04 | A novel tumor necrosis factor family member, drl, and related compositions and methods |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1467000A (en) |
WO (1) | WO2000026244A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541224B2 (en) | 1996-03-14 | 2003-04-01 | Human Genome Sciences, Inc. | Tumor necrosis factor delta polypeptides |
US7217788B2 (en) | 1996-03-14 | 2007-05-15 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta polypeptides |
US6689579B1 (en) | 1996-10-25 | 2004-02-10 | Human Genome Sciences, Inc. | Polynucleotides encoding neutrokine-α |
US6812327B1 (en) | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
PL198934B1 (en) | 1999-01-25 | 2008-08-29 | Apoxis Sa | Baff, related blocking agents and their use in the stimulation and inhibition of b-cells and immunoglobulins in immune responses |
US20030095967A1 (en) | 1999-01-25 | 2003-05-22 | Mackay Fabienne | BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders |
DK1210425T4 (en) | 1999-08-17 | 2015-08-10 | Apotech R & D Sa | BAFF receptor (BCMA), an immunoregulatory agent |
UA74798C2 (en) | 1999-10-06 | 2006-02-15 | Байоджен Айдек Ма Інк. | Method for treating cancer in mammals using polypeptide interfering with interaction between april and its receptors |
US7220840B2 (en) | 2000-06-16 | 2007-05-22 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
PT2275449T (en) | 2000-06-16 | 2016-12-27 | Human Genome Sciences Inc | Antibodies that immunospecifically bind to blys |
US20030091565A1 (en) | 2000-08-18 | 2003-05-15 | Beltzer James P. | Binding polypeptides and methods based thereon |
DE10045591A1 (en) * | 2000-09-15 | 2002-04-04 | Klaus Pfizenmaier | Site-specific, antibody-mediated activation of proapoptotic cytokines - AMAIZe (Antibody-Mediated Apoptosis Inducing Cytokines) |
UA83458C2 (en) | 2000-09-18 | 2008-07-25 | Байоджен Айдек Ма Інк. | The isolated polypeptide baff-r (the receptor of the factor of activation of b-cells of the family tnf) |
CA2446734A1 (en) | 2001-05-24 | 2002-11-28 | Human Genome Sciences, Inc. | Antibodies against tumor necrosis factor delta (april) |
US7700317B2 (en) | 2003-03-28 | 2010-04-20 | Biogen Idec Ma Inc. | Truncated baff receptors |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
WO2006044582A2 (en) | 2004-10-13 | 2006-04-27 | The Washington University | Use of baff to treat sepsis |
US9168286B2 (en) | 2005-10-13 | 2015-10-27 | Human Genome Sciences, Inc. | Methods and compositions for use in treatment of patients with autoantibody positive disease |
CA2629306A1 (en) | 2005-11-23 | 2007-05-31 | Genentech, Inc. | Methods and compositions related to b cell assays |
WO2007123765A2 (en) | 2006-03-31 | 2007-11-01 | Human Genome Sciences Inc. | Neutrokine-alpha and neutrokine-alpha splice variant |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994019463A2 (en) * | 1993-02-16 | 1994-09-01 | Auckland Uniservices Limited | Developmental tyrosine kinases and their ligands |
WO1997033902A1 (en) * | 1996-03-14 | 1997-09-18 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta and epsilon |
EP0869180A1 (en) * | 1997-04-02 | 1998-10-07 | Smithkline Beecham Corporation | A TNF homologue, TL5 |
WO1998055621A1 (en) * | 1997-06-06 | 1998-12-10 | Regeneron Pharmaceuticals, Inc. | Ntn-2 member of tnf ligand family |
WO1998055620A1 (en) * | 1997-06-06 | 1998-12-10 | Regeneron Pharmaceuticals, Inc. | Ntn-2 member of tnf ligand family |
WO1999011791A2 (en) * | 1997-09-05 | 1999-03-11 | University Of Washington | Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents |
EP0919620A2 (en) * | 1997-11-26 | 1999-06-02 | Eli Lilly And Company | TRAILLK-3: a member of the TNF ligand family |
WO1999028462A2 (en) * | 1997-12-03 | 1999-06-10 | Genentech, Inc. | Polypeptides and nucleic acids encoding the same |
-
1999
- 1999-11-04 WO PCT/US1999/025954 patent/WO2000026244A2/en active Application Filing
- 1999-11-04 AU AU14670/00A patent/AU1467000A/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994019463A2 (en) * | 1993-02-16 | 1994-09-01 | Auckland Uniservices Limited | Developmental tyrosine kinases and their ligands |
WO1997033902A1 (en) * | 1996-03-14 | 1997-09-18 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta and epsilon |
EP0869180A1 (en) * | 1997-04-02 | 1998-10-07 | Smithkline Beecham Corporation | A TNF homologue, TL5 |
WO1998055621A1 (en) * | 1997-06-06 | 1998-12-10 | Regeneron Pharmaceuticals, Inc. | Ntn-2 member of tnf ligand family |
WO1998055620A1 (en) * | 1997-06-06 | 1998-12-10 | Regeneron Pharmaceuticals, Inc. | Ntn-2 member of tnf ligand family |
WO1999011791A2 (en) * | 1997-09-05 | 1999-03-11 | University Of Washington | Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents |
EP0919620A2 (en) * | 1997-11-26 | 1999-06-02 | Eli Lilly And Company | TRAILLK-3: a member of the TNF ligand family |
WO1999028462A2 (en) * | 1997-12-03 | 1999-06-10 | Genentech, Inc. | Polypeptides and nucleic acids encoding the same |
Non-Patent Citations (1)
Title |
---|
HAHNE M ET AL: "APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth", JOURNAL OF EXPERIMENTAL MEDICINE,JP,TOKYO, vol. 188, no. 6, 21 September 1998 (1998-09-21), pages 1185 - 1190-1190, XP002099001, ISSN: 0022-1007 * |
Also Published As
Publication number | Publication date |
---|---|
AU1467000A (en) | 2000-05-22 |
WO2000026244A2 (en) | 2000-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000026244A3 (en) | A novel tumor necrosis factor family member, drl, and related compositions and methods | |
WO1999055868A3 (en) | Fizz proteins | |
Choi-Miura et al. | Identification of the disulfide bonds in human plasma protein SP-40, 40 (apolipoprotein-J) | |
BG102983A (en) | Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application | |
WO2001055364A3 (en) | Nucleic acids, proteins, and antibodies | |
WO1999060127A3 (en) | Il-17 homologous polypeptides and therapeutic uses thereof | |
NZ504548A (en) | Polypeptides and nucleic acids encoding human chordin | |
EP2327775A3 (en) | Therapy for alpha-galactosidase a deficiency | |
WO2002016418A3 (en) | An iap binding peptide or polypeptide and methods of using the same | |
AU4778101A (en) | Novel polypeptides, and nucleic acids encoding the same | |
CA2337100A1 (en) | Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same | |
WO2002008426A3 (en) | Fh-binding protein of streptococcus pneumoniae | |
WO2000066156A8 (en) | Death domain containing receptor 5 | |
WO2000020447A3 (en) | Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses | |
WO2002068459A3 (en) | Non aggregating fluorescent proteins and methods for using the same | |
AU5776799A (en) | Modified hcv peptide vaccines | |
WO2000039297A3 (en) | Il-1 related polypeptides | |
WO2000059942A3 (en) | Human obesity protein binding protrein-2 homolog and uses thereof | |
WO2001062928A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2001070978A3 (en) | Polypeptides and nucleic acids encoding same | |
EP0342173A3 (en) | Fibronectin binding protein as well as its preparation | |
CA2374513A1 (en) | Il-1 eta dna and polypeptides | |
WO2001036638A8 (en) | Polypeptides and nucleic acids encoding same | |
Tanaka et al. | Amino acid sequence of troponin-I from Akazara scallop striated adductor muscle | |
WO2000043419A3 (en) | Exocytosis pathway proteins and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref country code: AU Ref document number: 2000 14670 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |